The present invention is in the target with the left ventricular hypertrophy, target the physiologic LVH A method of diagnosing a pathological gatneunji or distinguish whether or suffering from left ventricular hypertrophy to a method comprising the following steps: a) at least one sample of the target, one or more marker selected from the necrosis markers, one or more marker selected from heart failure marker, and measuring the amount of one or more marker selected from inflammatory markers, b) step a) is the reference for measuring the amount of the measured amount of the marker in comparison to step and c) the target is to diagnose whether suffering from a physiological or pathological LVH after health. The invention also pathological the target suffering from left ventricular hypertrophy, as a method that enables the target hypertrophic non-obstructive cardiomyopathy, distinguish whether suffering from hypertrophic obstructive cardiomyopathy or pressure overload hypertrophy (diagnosis) may comprise the steps of, It relates to a method of: a) at least one sample of the target, more than one cardiac marker is selected from markers, one or more marker selected from the necrosis marker, and measuring the amount of one or more marker selected from inflammatory markers, b) comparing the quantity referring to the amount, and c) based on the results of step b), the step of distinguishing between different types of hypertrophic cardiomyopathy. In a preferred embodiment of the method of the present invention, the ratio of the two markers are formed. Optionally, the PlGF is measured as an additional marker. Furthermore, the present invention relates to a device and a kit adapted to carry out the method of the present invention. The invention also BNP (NT-proBNP), the troponin T or I, GDF-15 and PlGF, the target having a left ventricular hypertrophy, subject to distinguish whether or not suffering from or pathological LVH it has the physiological LVH relates to the use for.
